Form 4 for KRMD KORU Medical Systems, Inc.

Accepted 2022-04-13 00:00:00 ET · period of report 2022-03-04 · accession 0001161697-22-000181 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-04-13	2022-03-04	KRMD	Tharby Linda M	Pres, CEO	F - Tax	$3.03	-11.3K	1.02M	-1%	-$34.3K
	2022-04-13	2022-03-04	KRMD	Tharby Linda M	Pres, CEO	A - Grant	$3.03	+31.4K	1.03M	+3%	+$95.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-04	F	D	11,334	$3.03	1,020,107	D	—	—	(F3) Represents shares of common stock withheld by the issuer in satisfaction of tax withholding obligations upon the issuance of common stock for the portion of the 2021 bonus paid in equity. (F2) Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.
2	Common	Common Stock	2022-03-04	A	A	31,441	$3.03	1,031,441	D	—	—	(F1) Represents shares of common stock issued as a portion of the 2021 bonus paid in equity. (F2) Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.